Van Hulzen Asset Management, LLC Pacira Bio Sciences, Inc. Transaction History
Van Hulzen Asset Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Van Hulzen Asset Management, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 150 shares of PCRX stock, worth $3,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 71,172
99.79%
Holding current value
$3,736
Previous $1.07 Million
99.81%
% of portfolio
0.0%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding PCRX
# of Institutions
258Shares Held
49.2MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$199 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$131 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$81.3 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$56.2 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$49.6 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.14B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...